AUD 0.05
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -669.16 Thousand | -2 Million | -391.06 Thousand | -49.47 Thousand | -22.24 Thousand | -2130.00 |
Net Income | -799.05 Thousand | -2.13 Million | -445.2 Thousand | -53.15 Thousand | -26.64 Thousand | -4787.00 |
Depreciation & Amortization | 41.88 Thousand | 17.94 Thousand | - | - | - | - |
Deferred income taxes | -160.79 Thousand | -156.32 Thousand | - | - | - | - |
Stock-based compensation | 160.79 Thousand | 156.32 Thousand | - | - | - | - |
Change in working capital | -30.9 Thousand | -19.48 Thousand | 54.14 Thousand | 3683.00 | 4401.00 | 2657.00 |
Other non-cash items | 118.9 Thousand | 138.37 Thousand | -64.86 Thousand | -3683.00 | -4401.00 | -2657.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | -1.00 | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 1.4 Million | -37.85 Thousand | 4.93 Million | 49.98 Thousand | 10.44 Thousand | 14.03 Thousand |
Debt repayment | - | - | -41.4 Thousand | -29.88 Thousand | -10.52 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 1.4 Million | -37.85 Thousand | 4.97 Million | 20.1 Thousand | -72.00 | 14.03 Thousand |
Other Financing Activities | 1.4 Million | -37.85 Thousand | 1000.00 | 49.98 Thousand | 10.44 Thousand | - |
Accounts receivables | 16.07 Thousand | 11.63 Thousand | -42.21 Thousand | -1723.00 | -232.00 | -72.00 |
Accounts payables | -46.34 Thousand | -24.09 Thousand | 107.08 Thousand | 5406.00 | 4633.00 | 2729.00 |
Inventory | 1.00 | - | - | - | - | - |
Other working capital | -636.00 | -7028.00 | -10.72 Thousand | - | - | - |
Cash at beginning of period | 2.5 Million | 4.54 Million | 622.00 | 106.00 | 11.9 Thousand | - |
Cash at end of period | 3.23 Million | 2.5 Million | 4.54 Million | 622.00 | 106.00 | 11.9 Thousand |
Capital Expenditure | -1.00 | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 733.71 Thousand | -2.03 Million | 4.54 Million | 516.00 | -11.79 Thousand | 11.9 Thousand |
Free Cash Flow | -669.17 Thousand | -2 Million | -391.06 Thousand | -49.47 Thousand | -22.24 Thousand | -2130.00 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -122.24 Thousand | -122.24 Thousand | -177.12 Thousand | -799.05 Thousand | -177.12 Thousand | -444.8 Thousand |
Depreciation & Amortization | - | - | 20.94 Thousand | 41.88 Thousand | 20.94 Thousand | - |
Deferred income taxes | - | - | - | -160.79 Thousand | - | - |
Stock-based compensation | 24.02 Thousand | 24.02 Thousand | 36.57 Thousand | 160.79 Thousand | 36.57 Thousand | 43.82 Thousand |
Change in working capital | - | - | 7720.00 | -30.9 Thousand | 7720.00 | - |
Other non-cash items | -18.68 Thousand | -18.68 Thousand | -27.53 Thousand | 118.9 Thousand | -27.53 Thousand | 54.46 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | 1.4 Million | - | 1.4 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 1.4 Million | - | 1.4 Million |
Other Financing Activities | - | - | - | 1.4 Million | - | 701.44 Thousand |
Accounts receivables | - | - | 8038.00 | 16.07 Thousand | 8038.00 | - |
Accounts payables | - | - | - | -46.34 Thousand | - | - |
Inventory | - | - | - | 1.00 | - | - |
Other working capital | - | - | -318.00 | -636.00 | -318.00 | - |
Cash at beginning of period | - | - | 3.51 Million | 2.5 Million | 3.51 Million | 2.5 Million |
Cash at end of period | -116.89 Thousand | -116.89 Thousand | 3.23 Million | 3.23 Million | 3.37 Million | 3.51 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -116.89 Thousand | -116.89 Thousand | -278.83 Thousand | 733.71 Thousand | -139.41 Thousand | 1.01 Million |
Free Cash Flow | -116.89 Thousand | -116.89 Thousand | -139.41 Thousand | -669.16 Thousand | -139.41 Thousand | -390.33 Thousand |
ATH
8160
3539
MAGADSUGAR
EXCELINDUS
AARTIPHARM